281 related articles for article (PubMed ID: 7795447)
1. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.
Roberts RJ; Sandifer QD; Evans MR; Nolan-Farrell MZ; Davis PM
BMJ; 1995 Jun; 310(6995):1629-32. PubMed ID: 7795447
[TBL] [Abstract][Full Text] [Related]
2. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine.
Benjamin CM; Chew GC; Silman AJ
BMJ; 1992 Apr; 304(6834):1075-8. PubMed ID: 1586818
[TBL] [Abstract][Full Text] [Related]
3. The measles/rubella immunisation campaign in Scotland.
Skinner R; Christie P; Cowden JM
Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
[TBL] [Abstract][Full Text] [Related]
4. A retrospective cohort study of risk factors for missing preschool booster immunisation.
Evans MR; Thomas DR
Arch Dis Child; 1998 Aug; 79(2):141-4. PubMed ID: 9797595
[TBL] [Abstract][Full Text] [Related]
5. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting uptake of measles, mumps, and rubella immunisation.
Li J; Taylor B
BMJ; 1993 Jul; 307(6897):168-71. PubMed ID: 8343745
[TBL] [Abstract][Full Text] [Related]
7. Children who miss immunisation: implications for eliminating measles.
Evans MR
BMJ; 1995 May; 310(6991):1367-8. PubMed ID: 7787540
[No Abstract] [Full Text] [Related]
8. The Measles Control Campaign and immunisation adverse events.
Burgess MA; Heath TC; McIntyre PB
Commun Dis Intell; 1998 Jul; 22(7):136-8. PubMed ID: 9684532
[No Abstract] [Full Text] [Related]
9. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England.
Miller E; Waight P
BMJ; 1998 Jun; 316(7146):1745. PubMed ID: 9614036
[No Abstract] [Full Text] [Related]
10. Rates of first measles-mumps-rubella immunisation in Wales (UK).
Thomas DR; Salmon RL; King J
Lancet; 1998 Jun; 351(9120):1927. PubMed ID: 9654262
[No Abstract] [Full Text] [Related]
11. An outbreak of measles in a highly immunised population: immunisation status and vaccine efficacy.
Herceg A; Passaris I; Mead C
Aust J Public Health; 1994 Sep; 18(3):249-52. PubMed ID: 7841251
[TBL] [Abstract][Full Text] [Related]
12. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial.
Mason BW; Donnelly PD
Commun Dis Public Health; 2000 Mar; 3(1):67-8. PubMed ID: 10743326
[TBL] [Abstract][Full Text] [Related]
13. Bacterial meningitis after MMR immunisation.
Riordan FA; Sills JA; Thomson AP; Hart CA
Postgrad Med J; 1995 Dec; 71(842):745-6. PubMed ID: 8552541
[TBL] [Abstract][Full Text] [Related]
14. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
Amin J; Wong M
Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836
[No Abstract] [Full Text] [Related]
15. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
16. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
17. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.
Panagiotopoulos T; Antoniadou I; Valassi-Adam E
BMJ; 1999 Dec; 319(7223):1462-7. PubMed ID: 10582926
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.
Dourado I; Cunha S; Teixeira MG; Farrington CP; Melo A; Lucena R; Barreto ML
Am J Epidemiol; 2000 Mar; 151(5):524-30. PubMed ID: 10707922
[TBL] [Abstract][Full Text] [Related]
20. Mumps, measles and rubella vaccination: a pragmatic study.
Sutton GC
Public Health; 1991 Mar; 105(2):133-8. PubMed ID: 2068236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
